Scynexis (SCYX) Capital Expenditures (2013 - 2021)
Scynexis (SCYX) posted Capital Expenditures of -$478000.0 for Q4 2021, down 303.4% on a QoQ basis from $235000.0 in Q3 2021, and down 11850.0% year-over-year from N/an in Q4 2020.
Scynexis (SCYX) Capital Expenditures (2013 - 2021) Analysis & Trends
Scynexis' Capital Expenditures history runs 8 years deep, the most recent figure standing at -$478000.0 for Q4 2021.
- Quarterly Capital Expenditures fell 11850.0% year-over-year to -$478000.0 in Q4 2021, while the trailing twelve-month figure through Sep 2022 was -$478000.0 (down 186.59% YoY) and the FY2021 annual result came in at $78000.0, changed N/A from the prior year.
- Capital Expenditures was -$478000.0 for Q4 2021 at Scynexis, down from $235000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $400000.0 in Q2 2018 and bottomed at -$478000.0 in Q4 2021.
- A 4-year average of $58636.4 and a median of $67000.0 in 2018 frame the typical range for Capital Expenditures.
- Peak annual rise in Capital Expenditures reached 5775.0% in 2021, while the deepest fall reached 11850.0% in 2021.
- Scynexis' Capital Expenditures stood at $2000.0 in 2017, then surged by 4300.0% to $88000.0 in 2018, then slumped by 104.55% to -$4000.0 in 2020, then plunged by 11850.0% to -$478000.0 in 2021.
- Business Quant data shows SCYX's Capital Expenditures at -$478000.0 in Q4 2021, $235000.0 in Q3 2021, and $143000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 168.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 110.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 1.95 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 99.60 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 39.90 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.40 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 51.00 Mn |
| 10 | Scynexis | 23.19 Mn | -13.57 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -478,000.00 |
| Dec 31, 2021 | -478,000.00 |
| Sep 30, 2021 | 235,000.00 |
| Sep 30, 2021 | 235,000.00 |
| Jun 30, 2021 | 143,000.00 |
| Jun 30, 2021 | 143,000.00 |
| Mar 31, 2021 | 178,000.00 |
| Mar 31, 2021 | 178,000.00 |
| Dec 31, 2020 | -4,000.00 |
| Dec 31, 2020 | -4,000.00 |
| Sep 30, 2020 | 4,000.00 |
| Sep 30, 2020 | 4,000.00 |
| Dec 31, 2018 | 88,000.00 |
| Dec 31, 2018 | 88,000.00 |
| Sep 30, 2018 | 67,000.00 |
| Sep 30, 2018 | 67,000.00 |
| Jun 30, 2018 | 400,000.00 |
| Jun 30, 2018 | 400,000.00 |
| Mar 31, 2018 | 10,000.00 |
| Mar 31, 2018 | 10,000.00 |